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Objective: Fear of progression (FoP), also referred to as fear of cancer recurrence, is
gaining increasing interest in survivorship research as it constitutes a great burden
for patients and relatives. However, only little is known about FoP in parents of child-
hood cancer survivors. The objective of this study was to investigate the impact of
FoP on quality of life (QoL) in parental couples.
Methods: We analyzed dyadic data of 197 couples parenting childhood cancer survivors
(aged 0-17 years at diagnosis of leukemia or central nervous system tumor) after the end
of intensive cancer treatment. The actor-partner interdependence model calculated by
structural equation modelling was used to examine actor effects (effect of one's own FoP
on one's own QoL) and partner effects (effect of one's own FoP on the partner's QoL).
Results: Eighty-one percentage of the parents reported moderate or high FoP levels.
Mothers reported higher FoP levels (p < .01) and lower overall QoL levels than fathers
(p < .01). The results revealed a significantly positive intra-dyadic correlation between
FoP of mothers and fathers of the same dyad (r = .431, p < .001). We found significantly
negative actor effects for both mothers and fathers for the overall QoL (p < .001) as well
as for several QoL subscales. No significant partner effects were found.
Conclusions: Most parents reported elevated levels of FoP. Our results show that
FoP in parents of childhood cancer survivors is strongly negatively associated with
QoL. Parental FoP should therefore be explored in future research and needs to be
targeted by health care providers.
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1 | INTRODUCTION
Childhood cancer is the second leading cause of death in children in
high income countries.1 Each year, more than 2000 children in Germany
under 18 years of age are diagnosed with cancer.2 The 15-year survival
rate is approximately 80%.2 Consequently, the population of childhood
cancer survivors and their families is growing.1 Most families success-
fully readjust after the end of treatment and show distress levels com-
parable to normative samples.3,4 However, some parents still report
clinical levels of distress years after the end of treatment.3-5
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Fear of progression (FoP), also known as fear of cancer recur-
rence or fear of relapse, is gaining an increasing interest in adult survi-
vorship research.6 FoP describes a rationally explainable response to
the real threat of a potentially life-threatening cancer disease.7 It can
be defined as the “fear that the illness will progress with all its biopsy-
chosocial consequences, or that it will recur.”7 FoP in adult cancer
patients has been researched intensively.6 For a long time, FoP in par-
ents of childhood cancer survivors was only implicitly described in
qualitative studies.4,8-11 The Fear of Progression Questionnaire for the
parental perspective (FoP-Q-SF/PR) was published recently and offers
the opportunity to investigate parental FoP systematically.12,13 Paren-
tal FoP seems to be associated with anxiety, depression, posttraumatic
stress and a low quality of life (QoL).13 Further, significantly negative
correlations of FoP with time since diagnosis, anxiety coping skills of
the parents, parental age, the child's current medical condition and the
number of siblings were found.12 Significant gender differences in FoP
levels of mothers and fathers could not be found,12,14 nor was the chi-
ld's age at diagnosis associated with parental FoP.12 According to an
expert online survey in Germany, health care professionals are fre-
quently confronted with parental FoP in clinical practice.15 Addition-
ally, a recent interview study identified parental FoP as an impeding
factor when reintegrating into daily life after the end of treatment.16
Overall, research on FoP of parents of childhood cancer survivors
is still in its infancy. Previous studies used a broad sample of parents
from children still receiving cancer treatment to long-term survi-
vors.12-14 Further, most of the parents that participated in these stud-
ies already received psychosocial support.12-14 A family perspective
has not been considered yet, however, according to research on FoP
in adult patients, FoP seems to be a “family affair.”7 The aim of this
study was to investigate how FoP impacts the QoL of affected par-
ents using a dyadic data analysis approach. We decided for QoL as
the outcome, since it is commonly used for the assessment of the
multidimensional psychosocial situation of pediatric cancer patients
and their families.17-19 We additionally examined the association
between FoP and various QoL subscales (functioning, satisfaction
with the family situation, emotional distress, self-development, gen-
eral well-being) to elaborate on different aspects of QoL.
Based on earlier results we examined the following hypotheses12,13:
1. Actor effect: FoP in mothers/fathers of childhood cancer survivors
is negatively associated with their own QoL (overall QoL and QoL
subscales).
2. Partner effect: FoP in mothers/fathers of childhood cancer survi-




This dyadic data analysis was performed within a prospective obser-
vational study with a longitudinal mixed-methods design. The overall
study has been described in a study protocol20 and was reviewed and
approved by the Ethics Committee of the Medical Chamber of Ham-
burg (number: PV5277). The STROBE Statement was applied in the
reporting of this article.21
2.2 | Participants and procedure
In this study, we focused on the most frequent pediatric cancer diagno-
ses in Germany, leukemia and central nervous system (CNS) tumors.2
We included biological parents and other caregivers of children
(<18 years of age at diagnosis) after the end of intensive cancer treat-
ment (eg, chemotherapy). Exclusion criteria were assessed by the health
care providers in the clinics and were refusal of participation, physical
and/or mental burden (applicable if the study participation would be
overly burdensome), cognitive limitations and insufficient German lan-
guage skills. Written informed consent was obtained. The dyadic analysis
was performed with data of opposite-sex couples that both participated
in the study and that were still in a couple relationship. Same-sex couples
were excluded from the analysis because the statistical model requires
distinguishable couples (in our study distinguishable by gender).22
Parental couples were consecutively recruited in Germany from
July 2016 to March 2019 via two study arms: Firstly, we recruited
families via the International HIT-MED Registry (I-HIT-MED;
ClinicalTrials.gov Identifier: NCT02417324), the study registries of
the COALL 08-09 study (ClinicalTrials.gov Identifier: NCT01228331)
and the SIOP-LGG 2004 study (ClinicalTrials.gov Identifier:
NCT00276640). The study registries informed the patients' clinic after
the end of intensive cancer treatment about the study. Health care
providers at the clinics informed the families about the study and pas-
sed study information and a consent form to contact the family. The
research institute finally sent the families consent forms for participa-
tion and the questionnaires. Secondly, our cooperating rehabilitation
clinic informed families about the study and passed study information,
consent forms for participation and questionnaires to the families.
Parents were surveyed at the beginning of the rehabilitation measure.
A flowchart of the recruitment process can be found in Appendix A.
2.3 | Measures
2.3.1 | Sociodemographic and medical data
Sociodemographic information was extracted from the parents' ques-
tionnaire (age and gender of parents and child, number of siblings, par-
ent's education and employment status, relationship status of the
parental couple). Depending on the recruitment path, medical informa-
tion (diagnosis, time since diagnosis) was extracted from the parents'
reports or the physicians' questionnaire in the rehabilitation clinic.20
2.3.2 | Fear of progression
In this study, we used the 12-item Fear of Progression Questionnaire
- Parent Report (FoP-Q-SF/PR).12 Items are scored on a 5-point Likert
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scale ranging from never (1) to very often (5). A sum score between
12 and 60 can be calculated with higher scores indicating a higher
level of fear of progression. Schepper and colleagues recommended
preliminary cut-off values based on the mean value ±1 SD: 12 to 25
low FoP, 26 to 46 moderate FoP and 47 to 60 high FoP.12 The FoP-
Q-SF/PR shows good reliability and validity.12,13
2.3.3 | Quality of life
Parental QoL was measured with The Ulm Quality of Life Inventory
for Parents (ULQIE).23 The ULQIE measures QoL in parents of chroni-
cally ill children with 29 items on five subscales focusing on the past
week: Functioning, satisfaction with family situation, emotional dis-
tress, self-development and general well-being.23 Items are scored on
a 5-point Likert scale from never (0) to always (4). A total sum score
and subscale scores can be calculated. High sum scores indicate high
QoL. The ULQIE has adequate psychometric properties.23
2.4 | Statistical analyses
Sociodemographic and medical characteristics, group comparisons
(unpaired t-tests, Pearson chi square test) and intra-dyadic correla-
tions (Pearson correlations) were analyzed with the software IBM
SPSS Statistics 25. Alpha was for all analyses set at .05. Missing values
in the FoP and QoL measures were imputed with the individual mean
with a maximum of 30% missing data within one scale. The sample
size and power calculations were based on the main research ques-
tions in the overall study. Based on previous statistics and an esti-
mated 50% response rate, we expected a total number of 285 families
at the first measurement time point in the two study arms. An exten-
sion of the recruitment phase was necessary. A comprehensive
description is displayed in the study protocol.20
2.4.1 | Actor-partner interdependence
model (APIM)
When analyzing parental couple data, it is important to note that the
dyad members' responses might be dependent.24 This would lead to a
violation of the independence assumption in significance testing. The
actor-partner interdependence model (APIM) directly measures non-
independence by considering the dyad in the analysis.22,24 The APIM
examines actor effects (effect of one's own predictor on one's own
outcome) and partner effects (effect on one's own predictor on the
partner's outcome).22 We applied the APIM to calculate the effect of
one's own FoP on one's own QoL (actor effect) and the effect of one's
own FoP on the partner's QoL (partner effect).22 We conducted the
APIM using structural equation modeling (SEM) with maximum likeli-
hood estimation.25 The SEM was calculated with the program
lavaan26 within the app APIM_SEM.27 The parameter k is the ratio of
the partner effect to the actor effect and was calculated to detect
patterns in the APIM (couple pattern, contrast pattern, actor-only pat-
tern).28 The child's diagnosis (CNS tumor vs leukemia), time since diag-
nosis and the child's age were examined as potential confounders.
Controlling for confounders is recommended if variables correlate
with both the predictor (FoP) and the outcome (QoL) or with the out-
come only.27
3 | RESULTS
3.1 | Sample characteristics
Eight hundred ninety-nine families were potentially eligible for partici-
pation in the study (Appendix A). Three hundred twelve families par-
ticipated in the survey. Due to the complex recruitment process, we
could only indicate the reasons for the non-participation of the
60 families that were recruited at the rehabilitation clinic (n = 21
refusal of participation, n = 14 insufficient German language skills,
n = 12 physical and/or mental burden, n = 3 cognitive limitations,
n = 10 not specified). Five hundred twenty-seven families that were
recruited via the study registries did not participate because either
they did fulfil the exclusion criteria (refusal of participation, physical
and/or mental burden, cognitive limitations or insufficient German
language skills) or the health care providers in the clinics were not able
to inform them about the study. From the 312 families that partici-
pated in the study, five families were excluded subsequently (n = 2
missing consent forms for participation, n = 2 wrong diagnosis, n = 1
incorrectly answered questionnaires because of limited German lan-
guage skills). In this study, we analyzed the dyadic data of 197 parental
couples (107 families recruited at the rehabilitation clinic and 90 via the
study registries). Table 1 provides an overview of the relevant
sociodemographic and medical data of parents and patients. There were
no significant differences in time since diagnosis (t[366.530] = 1.801,
p = .072) and FoP levels (t[389] = −0.811, p = .418) between parents in
the two recruitment paths. However, we found that parents recruited
at the rehabilitation clinic reported significantly lower QoL levels than
parents recruited via the study registries (t[388] = −2.088, p < .05).
3.2 | FoP and QoL in mothers and fathers
Descriptive data on parent's FoP and QoL as well as gender differ-
ences are presented in Table 2.
3.3 | Confounders
We found significantly positive correlations between FoP and diagno-
sis (r = .206, p < .001), time since diagnosis (r = .194, p < .001) and chi-
ld's age (r = .108, p < .05). FoP in parents of CNS tumor survivors was
significantly higher than in parents of leukemia survivors (t
[389] = −4.160, p < .001). Longer time since diagnosis and higher chi-
ld's age were associated with higher levels of FoP. However, there was
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no significant difference in the QoL levels of parents of CNS tumor and
leukemia survivors and no significant correlations with QoL. Therefore,
we did not control for any confounders in this dyadic analysis.
3.4 | Main findings
Our results revealed a significantly negative actor effect from FoP
on the overall QoL for mothers and fathers (Table 3, Figure 1). We
also found significantly negative actor effects for both parents for
the QoL subscales functioning, emotional distress and general
well-being. A significantly negative actor effect for the subscale
satisfaction with the family situation was only found for fathers.
The results revealed no significant actor effects for the subscale
self-development.
No significant partner effects were found for any of the QoL
scales. However, the intra-dyadic correlation of mothers and fathers
of the same dyad was significantly positive for both FoP (r = .431,
p < .001) and the overall QoL (r = .277, p < .001). An actor-only model
(k = 0) for the effect from FoP on the overall QoL was plausible for
mothers and fathers since 0 was included in both confidence
intervals.28
4 | DISCUSSION
The aim of this study was to investigate the impact of FoP on QoL in
parents of childhood cancer survivors using a dyadic data analysis
approach. Moderate to high levels of FoP were found in 81% of the
parents after the end of intensive cancer treatment. FoP levels in our
TABLE 1 Sociodemographic and
medical data of 394 parents and 197
pediatric cancer patients
Sociodemographic data
Total (n = 394) Fathers (n = 197) Mothers (n = 197)
Parents M SD/range M SD/range M SD/range
Age in yearsa 39.4 7.1/22-70 40.9 7.6/23-70 38.0 6.3/22-60
n % n % n %
Educationb
> 10 years 198 52.5 100 53.8 98 51.3
≤ 10 years 179 47.5 86 46.2 93 48.7
Employment statusc
Gainfully employed 298 76.6 181 92.8 117 60.3
Full-time 182 61.1 164 90.6 18 15.4
Part-time 116 38.9 17 9.4 99 84.6
Not gainfully employed 62 15.9 10 5.1 52 26.8
Home makers 43 69.4 1 10.0 42 80.8
Seeking employment 14 22.6 6 60.0 8 15.4
Retired 5 8.1 3 30.0 2 3.8
Other 29 7.5 4 2.1 25 12.9
Patients
Total (n = 197) Boys (n = 109) Girls (n = 88)
M SD/range M SD/range M SD/range
Age in years 6.9 4.3/1–18 7.6 4.5/1–18 6.1 4.0/1-16
Time since diagnosis
in months
19.0 17.8/5-129 19.2 18.0/6-129 18.9 17.6/5-121
n % n % n %
Number of siblingsd
0 33 17.1 15 13.9 18 21.2
1–2 147 76.2 84 77.8 63 74.1
> 2 13 6.7 9 8.3 4 4.7
Cancer diagnosis
CNS tumor 102 51.8 62 56.9 40 45.5
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sample were only slightly lower than in a sample of parents of children
up to 10 years after diagnosis of childhood cancer.13 The mean QoL
sum score in our sample was higher than the QoL score in a popula-
tion of parents of childhood cancer patients in the first 2 weeks post
diagnosis, but lower than the QoL score of healthy controls.29 In con-
trast to earlier studies, we found a significant gender difference
between mothers and fathers with mothers reporting higher levels of
FoP.12,14 Additionally, mothers reported a lower QoL than fathers. It
is possible that mothers reported higher burden because they might
be the primary carer of the child. Only a few mothers but most of the
fathers were working full time. Besides, men reporting lower levels of
psychosocial burden is a common finding.30 As expected, our results
display that FoP in mothers and fathers affected the overall QoL
(actor effects). We also found a negative impact of FoP on parental
functioning, emotional distress and general well-being. FoP also
affects the father's satisfaction with the family situation. Self-
development of parents was not affected by their FoP.
The results of our study also support the assumption that FoP is a
“family affair.”7 FoP in mothers and fathers of the same family were
highly correlated. We found a higher intra-dyadic correlation for FoP
than for QoL. It is possible that FoP levels are more similar in couples
because FoP describes the worry about the couple's child. Further,
FoP might be highly influenced by family factors (eg, time since diag-
nosis) whereas QoL is a multidimensional outcome that might also be
affected by various factors outside the family system (eg, job satisfac-
tion). However, there was no association between the FoP of one par-
ent and the QoL of the other parent. One possible reason for this
result is the high intra-dyadic correlation between FoP of mothers
and fathers from the same family. The partner effect may be con-
founded by the shared dyadic variance.31
FoP was higher in parents of CNS tumor survivors in comparison
to parents of leukemia survivors. A correlation of FoP with the actual
risk of progression which is higher in CNS tumor survivors is possible.2
FoP might be associated with a higher age of the child because par-
ents of older children potentially perceive their child's limitations as
more severe. A longer time since diagnosis was also associated with
higher FoP levels in parents. From a clinical perspective, this might be
caused by extending intervals between aftercare appointments. How-
ever, since 82% of the families were surveyed in the first 2 years after
diagnosis, we cannot make a reliable statement on the course of FoP.
4.1 | Study limitations
For reasons of data protection, we could not contact the parents
directly. Thus, we recruited the parents via a rehabilitation clinic and
study registries. Our complex recruitment process did not allow for a
systematic non-responder analysis. Therefore, the generalizability of
the results might be limited. Furthermore, we excluded parents with
particularly high levels of physical or mental burden due to ethical
considerations. Hence, an underreporting of FoP in our study is
possible.
This study has also several strengths. We surveyed parents of
childhood cancer survivors throughout Germany and reached a large
sample size. Moreover, this is the first study that investigated the
association of FoP and QoL in parents of childhood cancer survivors
in consideration of intra-dyadic processes.22,24
4.2 | Clinical implications
The results of this study display that most parents show moderate to
high levels of FoP even after intensive treatment has ended. Addition-
ally, this study provides evidence on the negative impact of parental
TABLE 2 Descriptive data on parents' FoP and QoL
Total (n = 394) Fathers (n = 197) Mothers (n = 197)
M SD/range M SD/range M SD/range t p
QoLa23
Overall QoL 67.6 17.3/26-109 70.2 17.3/27-109 65.0 17.0/26-105 −3.003 .003
Functioning 16.1 5.2/2-28 16.9 5.3/2–28 15.4 5.0/5-27 −2.862 .004
Satisfaction with family situation 17.7 4.3/4-24 18.0 4.1/5-24 17.4 4.4/4–24 −1.312 .190
Emotional distress 8.7 3.4/0-16 9.1 3.5/0–16 8.2 3.3/1-15 −2.666 .008
Self-development 5.8 3.0/0-14 6.1 2.9/0–14 5.5 3.0/0–14 −1.815 .070
General Well-Being 9.5 3.0/2–16 9.9 3.1/2–16 9.1 2.9/3-16 −2.638 .009
FoPb12 33.2 9.3/13-60 32.0 9.7/14-58 34.4 8.7/13–60 2.666 .008
FoP cut-offsb12 n % n % n % χ2 p
Low 76 19.4 50 25.8 26 13.2 9.999 .007
Moderate 280 71.6 127 65.5 153 77.7
High 35 9.0 17 8.8 18 9.1
a3 to 5 missings.
b3 missings.
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TABLE 3 Results of the actor-partner interdependence model (APIM)
Effect Estimate 95% confidence interval p Beta(s)a rb
Overall QoL
Mothers Intercept 91.162 [81.480, 100.844] <.001
Actor −0.799 [−1.078, −0.520] <.001 −0.409 −0.377
Partnerc 0.042 [−0.208, 0.292] .741 0.024 0.027
k −0.053 [−0.358, 0.252]
Fathers Intercept 96.340 [86.803, 105.877] <.001
Actor −0.874 [−1.118, −0.630] <.001 −0.490 −0.451
Partnerd 0.052 [−0.222, 0.325] .711 0.026 0.032
k −0.059 [−0.365, 0.247]
Functioning
Mothers Intercept 21.708 [18.752, 24.665] <.001
Actor −0.206 [−0.291, −0.121] <.001 −0.354 −0.324
Partnerc 0.023 [−0.053, 0.100] .546 0.045 0.049
k −0.114 [−0.466, 0.238]
Fathers Intercept 22.917 [19.812, 26.021] <.001
Actor −0.220 [−0.299, −0.140] <.001 −0.399 −0.364
Partnerd 0.029 [−0.060, 0.118] .527 0.047 0.048
k −0.131 [−0.518, 0.256]
Satisfaction with family situation
Mothers Intercept 19.800 [17.099, 22.501] <.001
Actor −0.055 [−0.133, 0.023] .168 −0.108 −0.100
Partnerc −0.016 [−0.086, 0.054] .651 −0.036 −0.029
k 0.293 [−1.207, 1.793]
Fathers Intercept 20.946 [18.437, 23.455] <.001
Actor −0.113 [−0.177, −0.049] <.001 −0.267 −0.238
Partnerd 0.018 [−0.054, 0.090] .623 0.038 0.038
k −0.159 [−0.761, 0.443]
Emotional distress
Mothers Intercept 15.572 [13.867, 17.276] <.001
Actor −0.218 [−0.267, −0.169] <.001 −0.570 −0.531
Partnerc 0.004 [−0.040, 0.048] .849 0.013 0.020
k −0.020 [−0.219, 0.180]
Fathers Intercept 15.583 [13.785, 17.381] <.001
Actor −0.207 [−0.253, −0.161] <.001 −0.577 −0.536
Partnerd 0.005 [−0.046, 0.057] .846 0.013 0.018
k −0.025 [−0.271, 0.222]
Self-development
Mothers Intercept 8.200 [6.396, 10.004] <.001
Actor −0.043 [−0.095, 0.009] .108 −0.125 −0.118
Partnerc −0.037 [−0.084, 0.009] .116 −0.122 −0.114
k 0.873 [−0.949, 2.695]
Fathers Intercept 8.517 [6.714, 10.320] <.001
Actor −0.044 [−0.091, 0.002] .060 −0.146 −0.136
Partnerd −0.030 [−0.082, 0.022] .256 −0.089 −0.079
k 0.677 [−0.929, 2.283]
(Continues)
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FoP on various aspects of their QoL. Therefore, health care pro-
fessionals should provide appropriate support to address elevated
levels of parental FoP. It is necessary to find a way to identify
parents in need of psychosocial support. So far, only cut-off
scores based on statistical considerations are available.12,32 When
developing new support offers, it should be considered that child-
hood cancer is rather rare. Thus, regionally independent support
measures, such as computer-based support offers, are highly
desirable.
5 | CONCLUSIONS
FoP in parents of childhood cancer survivors has not been adequately
investigated yet. In this study, most parents of childhood cancer survi-
vors reported elevated levels of FoP after the end of intensive cancer
treatment. FoP in mothers and fathers was negatively associated with
their own QoL but not with their partner's QoL. We also found a posi-
tive correlation between FoP in mothers and fathers of the same
child. Psychosocial support is highly indicated to target dysfunctional
levels of FoP in parents and to enhance their QoL after their child's
cancer treatment.
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TABLE 3 (Continued)
Effect Estimate 95% confidence interval p Beta(s)a rb
General well-being
Mothers Intercept 12.760 [11.074, 14.447] <.001
Actor −0.140 [−0.188, −0.091] <.001 −0.414 −0.378
Partnerc 0.037 [−0.007, 0.080] .099 0.121 0.123
k −0.262 [−0.546, 0.022]
Fathers Intercept 14.885 [13.173, 16.597] <.001
Actor −0.159 [−0.203, −0.116] <.001 −0.495 −0.456
Partnerd 0.004 [−0.045, 0.053] .868 0.012 0.014
k −0.026 [−0.331, 0.279]
aBeta(s) uses the SD for mothers and fathers separately.
bPairwise partial correlation.
cPartner effect from fathers to mothers.
dPartner effect from mothers to fathers.
F IGURE 1 Actor-partner interdependence model (APIM) for the
effect of FoP on the overall QoL with standardized parameter
estimates b(s) (*** p < .001)
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